# VERA BRADLEY, INC. (VRA) · Edgar & Edgarette company card

> Vera Bradley (VRA) saw revenue fall 15.4% in FY2026 to $270 million, operating margin -11.8%, equity 56.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1495320 · fiscal year ended 2026-01-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/VRA) · [JSON](https://www.pops4.com/boards/company/VRA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $270M |
| Revenue growth, 1 year | -15.4% |
| Revenue growth per year | -15.9% |
| Operating margin | -11.8% (prior year -9.0%) |
| Net margin | -17.7% |
| Operating cash flow | −$10M |
| Capital spending | $3M |
| Free cash flow | −$13M |
| Cash | $19M |
| Long-term debt | — |
| Total assets | $234M |
| Total equity | $132M |
| Equity ÷ assets | 56.3% |
| Return on equity | -36.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.78 (safe zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -2.94 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -11.8% in FY2026
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $269.7M (FY2026). Experience: revenue down 15.4% on the year, down 15.9% a year over 4 years; operating margin -11.8%, down from -9.0%. Soundness: equity 56.3% of assets, return on equity -36.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $175.8M and $274.5M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $157.0M to $308.6M. A statistical range, not company guidance.

Range logged 2026-09-29, receipt d67daab0acbd01cd, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-07-24 ([filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026049595/0001628280-26-049595-index.htm))

## Recent filings

- 10-Q · filed 2026-09-15 · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026062019/0001628280-26-062019-index.htm)
- 8-K · filed 2026-09-15 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026061971/0001628280-26-061971-index.htm)
- 8-K · filed 2026-07-24 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026049595/0001628280-26-049595-index.htm)
- 10-Q · filed 2026-06-11 · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026042444/0001628280-26-042444-index.htm)
- 8-K · filed 2026-06-11 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026042374/0001628280-26-042374-index.htm)
- 8-K · filed 2026-06-09 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1495320/000162828026041779/0001628280-26-041779-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001495320.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1495320

## Cite

POPS4, Edgar & Edgarette: VERA BRADLEY, INC. (VRA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/VRA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.